Cargando…

Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.

The importance of cytochrome P450 isoforms to species differences in the metabolism of foreign compounds and activation of procarcinogens has been identified. The possible range of P450 isozymes in significant variations in toxicity exhibited by experimental rodent species may have a relevance to ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, D F, Ioannides, C, Parke, D V
Formato: Texto
Lenguaje:English
Publicado: 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533178/
https://www.ncbi.nlm.nih.gov/pubmed/9755138
_version_ 1782128997488918528
author Lewis, D F
Ioannides, C
Parke, D V
author_facet Lewis, D F
Ioannides, C
Parke, D V
author_sort Lewis, D F
collection PubMed
description The importance of cytochrome P450 isoforms to species differences in the metabolism of foreign compounds and activation of procarcinogens has been identified. The possible range of P450 isozymes in significant variations in toxicity exhibited by experimental rodent species may have a relevance to chemical risk assessment, especially as human P450s are likely to show changes in the way they metabolize xenobiotics. Consequently, in the safety evaluation of chemicals, we should be cautious in extrapolating results from experimental animal models to humans. This paper focuses on examples in which species differences in P450s lead to significant alterations in carcinogenic response, and includes a discussion of the current procedures for toxicity screening, with an emphasis on short-term tests.
format Text
id pubmed-1533178
institution National Center for Biotechnology Information
language English
publishDate 1998
record_format MEDLINE/PubMed
spelling pubmed-15331782006-08-08 Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Lewis, D F Ioannides, C Parke, D V Environ Health Perspect Research Article The importance of cytochrome P450 isoforms to species differences in the metabolism of foreign compounds and activation of procarcinogens has been identified. The possible range of P450 isozymes in significant variations in toxicity exhibited by experimental rodent species may have a relevance to chemical risk assessment, especially as human P450s are likely to show changes in the way they metabolize xenobiotics. Consequently, in the safety evaluation of chemicals, we should be cautious in extrapolating results from experimental animal models to humans. This paper focuses on examples in which species differences in P450s lead to significant alterations in carcinogenic response, and includes a discussion of the current procedures for toxicity screening, with an emphasis on short-term tests. 1998-10 /pmc/articles/PMC1533178/ /pubmed/9755138 Text en
spellingShingle Research Article
Lewis, D F
Ioannides, C
Parke, D V
Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title_full Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title_fullStr Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title_full_unstemmed Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title_short Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
title_sort cytochromes p450 and species differences in xenobiotic metabolism and activation of carcinogen.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533178/
https://www.ncbi.nlm.nih.gov/pubmed/9755138
work_keys_str_mv AT lewisdf cytochromesp450andspeciesdifferencesinxenobioticmetabolismandactivationofcarcinogen
AT ioannidesc cytochromesp450andspeciesdifferencesinxenobioticmetabolismandactivationofcarcinogen
AT parkedv cytochromesp450andspeciesdifferencesinxenobioticmetabolismandactivationofcarcinogen